Noninvasive mechanical ventilation assistance in amyotrophic lateral sclerosis: a systematic review
Keywords:
Amyotrophic lateral sclerosis, Respiratory insufficiency, Noninvasive ventilation, Survival, Quality of life, Motor neuron diseases, Respiratory failure, Hypoventilations, Artificial respiration, Health system, Health, attitude toAbstract
BACKGROUND: Respiratory failure is the most common cause of death in patients with amyotrophic lateral sclerosis (ALS), and morbidity is related to poor quality of life (QOL). Non-invasive ventilation (NIV) may be associated with prolonged survival and QOL in patients with ALS.
OBJECTIVES: To assess whether NIV is effective and safe for patients with ALS in terms of survival and QOL, alerting the health system.
DESIGN AND SETTING: Systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting standards using population, intervention, comparison, and outcome strategies.
METHODS: The Cochrane Library, CENTRAL, MEDLINE, LILACS, EMBASE, and CRD databases were searched based on the eligibility criteria for all types of studies on NIV use in patients with ALS published up to January 2022. Data were extracted from the included studies, and the findings were presented using a narrative synthesis.
RESULTS: Of the 120 papers identified, only 14 were related to systematic reviews. After thorough reading, only one meta-analysis was considered eligible. In the second stage, 248 studies were included; however, only one systematic review was included. The results demonstrated that NIV provided relief from the symptoms of chronic hypoventilation, increased survival, and improved QOL compared to standard care. These results varied according to clinical phenotype.
CONCLUSIONS: NIV in patients with ALS improves the outcome and can delay the indication for tracheostomy, reducing expenditure on hospitalization and occupancy of intensive care unit beds.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO database: CRD42021279910 — https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=279910.
Downloads
References
Chiò A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118-30. PMID: 23860588; https://doi.org/10.1159/000351153.
Rocha JA, Reis C, Simões F, Fonseca J, Mendes Ribeiro J. Diagnostic investigation and multidisciplinary management in motor neuron disease. J Neurol. 2005;252(12):1435-47. PMID: 16362828; https://doi. org/10.1007/s00415-005-0007-9.
Lechtzin N. Respiratory effects of amyotrophic lateral sclerosis: problems and solutions. Respir Care. 2006;51(8):871-81; discussion 881-4. PMID: 16867198.
Prado Lde G, Bicalho IC, Vidigal-Lopes M, et al. Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):282-8. PMID: 26854959; https://doi.org/10.3109/21678421.2016.1143011.
Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;10(10):CD004427. PMID: 28982219; https://doi.org/10.1002/14651858.CD004427.pub4.
Khamankar N, Coan G, Weaver B, Mitchell CS. Associative increases in amyotrophic lateral sclerosis survival duration with non-invasive
ventilation initiation and usage protocols. Front Neurol. 2018;9:578. PMID: 30050497; https://doi.org/10.3389/fneur.2018.00578.
Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence- based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23. PMID: 10227612; https://doi. org/10.1212/wnl.52.7.1311.
Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi
S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14:579. PMID: 25413154; https://doi.org/10.1186/ s12913-014-0579-0.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. PMID: 19621072; https:// doi.org/10.1371/journal.pmed.1000097.
da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508-11. PMID: 17653438; https:// doi.org/10.1590/s0104-11692007000300023.
Howick J, Chalmers I, Glasziou P, et al. The Oxford 2011 Levels of Evidence. Oxford: Oxford Centre for Evidence-Based Medicine; 2011. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm- levels-of-evidence. Accessed in 2023 (March 22).
Berlowitz DJ, Howard ME, Fiore JF Jr, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry. 2016;87(3):280-6. PMID: 25857659; https://doi.org/10.1136/jnnp-2014-
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017;81(4):479-84. PMID: 28198092; https://doi.org/10.1002/ana.24897.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
